Ky. Woman Sues Bayer over Yaz Blood Clot Injuries

Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.

A Kentucky woman filed a Yaz lawsuit against Bayer Pharmaceuticals for injuries she allegedly sustained by taking the company’s popular birth control pill. Plaintiff Vanessa Allen’s Yaz lawsuit alleges that she suffered blood clot injuries from taking Yaz.

According to her Yaz lawsuit, Allen had been prescribed Yaz after choosing it as her method of contraceptive. She suffered no initial complications and used the product according to the  instructions.

On May 17, 2013, Allen was diagnosed with a pulmonary embolism. She says she filed the Yaz lawsuit because of the lack of warnings about the risks of taking the drug. Allen asserts that Bayer had the responsibility to warn her and other patients of these possible side effects. She says she would not have used the drug if she had known that blood clot injuries were a possible side effect.

Allen’s Yaz lawsuit accused Bayer Pharmaceuticals of negligence, false advertising, concealing information, and misrepresenting a product.

Overview of Yaz Complications

Yaz was first approved by the U.S. Food and Drug Administration in 2006 as an oral contraceptive and a treatment product for mild acne. Along with Yasmin and its generic cousin Ocella, it uses the newly-synthesized hormone drospirenone.

Due to Bayer’s aggressive advertising, Yaz has become one of the most popularly prescribed birth control pills in the country. Despite its popularity, several concerns over drospirenone have arisen. Doctors are concerned about whether the progestin is safe. One known fact about drospirenone is that it is a diuretic, leading doctors to believe it causes the blood clot injuries that Yaz, Yasmin and Ocella are commonly associated with. Diuretics slow the flow of the blood in the body by raising its potassium levels, which allows for the possibility of blood clot formation.

In 2008, the FDA announced that between 2004 and 2008, more than 50 deaths had been reported, allegedly caused by Yaz, Yasmin and Ocella. These deaths were due to cardiac arrhythmia, cardiac arrest, intracardiac thrombus, pulmonary embolism and stroke. Despite this and other scientific evidence, the Yaz warning label does not include the possibility of blood clot injuries.

The Yaz lawsuit is filed as part of multidistrict litigation titled in Re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Relevant Products Liability Litigation, MDL No. 2100, in the U.S. District Court for the Southern District of Illinois.

Join a Free Yaz Class Action Lawsuit Investigation

If you or someone you know suffered a birth control blood clot injury such as a stroke, heart attack, deep vein thrombosis, or pulmonary embolism, you have legal options. See if you qualify for compensation by submitting your information for a free and confidential case evaluation:

Oops! We could not locate your form.